If you’re looking for biotech stocks to buy, the iShares Biotechnology ETF (NASDAQ:IBB) is an excellent place to start. It tracks the performance of the ICE Biotechnology Index, a collection of ...

You should consider the iShares Biotechnology ETF (IBB), a passively managed exchange traded fund launched on 02/05/2001. While an excellent vehicle for long term investors, passively managed ETFs ...

International Assets Investment Management LLC bought a new position in shares of iShares Biotechnology ETF during the fourth quarter valued at about $563,000. Principal Securities Inc. bought a ...

Certuity LLC decreased its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 22.5% during the 2nd quarter, according to the company in its most recent disclosure with the ...

Healthcare ETFs hold the potential for higher returns, diversification, and exposure to stably growing companies. Therefore, ...

Short interest in iShares Biotechnology ETF (NASDAQ:IBB) increased during the last reporting period, rising from 10.14M to 10.18M. This put -% of the company's publicly available shares short.

These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these ...

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the Invesco Biotechnology & Genome ETF (PBE), a passively managed exchange traded ...

With numerous advancements and innovations in technology boosting the industry’s growth, investing in tech ETFs can offer ...

The US Securities and Exchange Commission has approved Nasdaq Inc.’s application to list options on the iShares Bitcoin Trust ...

If you are looking to add Bitcoin to your portfolio, the iShares Bitcoin Trust ETF is a way to do it. But is it really worth ...

iShares Biotechnology ETF earns an Average Process Pillar rating. The leading factor in the rating is the firm's retention rate of the firm's portfolio managers, which is 92% over the timeframe ...